Providers Are Pleased, PhRMA Isn’t, With Becerra and State AGs’ 340B Letter to Azar In Federal, Other Industry, Pharma Industry, Regulatory, State, Trade Association, UncategorizedDecember 15, 2020 Tom Mirga SPONSORED BYEditor’s note—A cascade of breaking 340B news … Read More »
BREAKING: 28 State AGs—Including HHS Nominee Becerra—Want Action on Pharma 340B Pricing Denials. Also, New GAO Report on HRSA 340B Oversight. (Updated) In Breaking, Federal, Regulatory, Research/Reports, StateDecember 14, 2020 Tom Mirga SPONSORED BY340B Report will be available exclusively to … Read More »
BREAKING: Hospitals Sue HHS Over Drug Companies’ Denials of 340B Pricing In Breaking, Federal, Judicial, Pharma Industry, Regulatory, Trade AssociationDecember 12, 2020 Tom Mirga … Read More »
After a 10-Year Odyssey, HRSA Finally Releases 340B Dispute Resolution Rule (Updated) In Federal, RegulatoryDecember 10, 2020 Tom Mirga … Read More »
BREAKING: 340B Dispute Resolution Final Rule Released In Breaking, Federal, RegulatoryDecember 10, 2020 Tom Mirga … Read More »
BREAKING: Amgen Ending 340B-Like Price Reductions on Orphan Drugs on Jan. 1 (Updated) In Breaking, Legislative, Pharma IndustryDecember 9, 2020 Tom Mirga … Read More »
White House Clears 340B Dispute Resolution Final Rule for Publication In Federal, RegulatoryDecember 8, 2020 Tom Mirga … Read More »
BREAKING: Florida Medicaid Asks Rx Manufacturer to Suspend “Broad Brush” 340B Pricing Restrictions, Will Other States Follow? In Breaking, Pharma Industry, Regulatory, StateDecember 3, 2020 Tom Mirga … Read More »
340B Hospitals Face Another Year of Deeply Reduced Medicare Drug Reimbursement In Federal, RegulatoryDecember 3, 2020 Tom Mirga … Read More »
BREAKING: Novo Nordisk Will Cease 340B Pricing for Hospital Contract Pharmacies on Jan. 1 In Breaking, Federal, Pharma Industry, RegulatoryDecember 1, 2020 Tom Mirga … Read More »
… 
… 
… 
… 
… 
… 
… 
…